Addus HomeCare Corporation (ADUS)
NASDAQ:ADUS
Want to see ADUS full AI Analyst Report?
ADUS Stock Chart & Stats
$94.32
-$0.15(-0.12%)
At close: 4:00 PM EST
$94.32
-$0.15(-0.12%)
Day’s Range― - ―
52-Week Range$87.95 - $124.44
Previous CloseN/A
Volume20.85K
Average Volume (3M)234.27K
Market Cap
$1.76B
Enterprise Value$1.79B
Total Cash (Recent Filing)$103.06M
Total Debt (Recent Filing)$138.74M
Price to Earnings (P/E)17.5
Beta0.38
Next Earnings
Aug 03, 2026EPS Estimate
1.69Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)5.41
Shares Outstanding18,664,776
10 Day Avg. Volume213,036
30 Day Avg. Volume234,267
Financial Highlights & Ratios
PEG Ratio1.04
Price to Book (P/B)1.83
Price to Sales (P/S)1.39
P/FCF Ratio19.09
Enterprise Value/Market Cap1.02
Enterprise Value/Revenue1.23
Enterprise Value/Gross Profit3.80
Enterprise Value/Ebitda11.10
Forecast
1Y Price Target
$129.38Price Target Upside37.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)6.99
Revenue Forecast (FY)$1.52B
Bulls Say, Bears Say
Bulls Say
Cash GenerationMaterial free cash flow (rising from ~$35M in 2021 to ~$137M TTM) and strong Q1 operating cash flow provide durable internal funding. This underpins capex, targeted M&A and working capital needs, reducing reliance on external financing and supporting long‑term financial flexibility.
Conservative Balance SheetLow and falling leverage (debt/equity ~0.12 TTM) with meaningful equity growth creates a resilient capital structure. That conservatism supports continued M&A, absorbs reimbursement volatility from government payors and preserves optionality for investments without stressing interest coverage.
Market Position & M&A MomentumA dominant, growing personal care franchise (77% of revenue with solid same-store gains) plus disciplined bolt-on acquisitions (Indiana entry via HomeCourt) supports scale economics, local density and cross-selling of hospice/home-health, creating durable growth channels beyond organic demand.
Bears Say
2025 Revenue SlowdownA pronounced growth slowdown in 2025 indicates demand normalization or tougher comps. If sustained, it limits the company’s ability to leverage fixed costs for margin expansion and raises the bar for M&A to fill organic shortfalls, challenging multi-year topline momentum assumptions.
Worsening Receivables / DSOA sharp jump in days‑sales‑outstanding lengthens cash conversion and increases working capital needs versus receipts from government payors. Persistently higher DSOs can pressure liquidity, elevate borrowing reliance and weaken the effective free cash flow available for growth or returns.
Home Health Weakness / Limited DiversificationHome health is a small, declining component of revenue, reducing diversification across service lines. Continued contraction here increases reliance on personal care and hospice, concentrating exposure to state Medicaid dynamics and specific reimbursement pressures over the medium term.
Addus Homecare News
ADUS FAQ
What was Addus HomeCare Corporation’s price range in the past 12 months?
Addus HomeCare Corporation lowest stock price was $87.95 and its highest was $124.44 in the past 12 months.
What is Addus HomeCare Corporation’s market cap?
Addus HomeCare Corporation’s market cap is $1.76B.
When is Addus HomeCare Corporation’s upcoming earnings report date?
Addus HomeCare Corporation’s upcoming earnings report date is Aug 03, 2026 which is in 43 days.
How were Addus HomeCare Corporation’s earnings last quarter?
Addus HomeCare Corporation released its earnings results on May 04, 2026. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.545 by $0.075.
Is Addus HomeCare Corporation overvalued?
According to Wall Street analysts Addus HomeCare Corporation’s price is currently Undervalued.
Does Addus HomeCare Corporation pay dividends?
Addus HomeCare Corporation does not currently pay dividends.
What is Addus HomeCare Corporation’s EPS estimate?
Addus HomeCare Corporation’s EPS estimate is 1.69.
How many shares outstanding does Addus HomeCare Corporation have?
Addus HomeCare Corporation has 18,664,776 shares outstanding.
What happened to Addus HomeCare Corporation’s price movement after its last earnings report?
Addus HomeCare Corporation reported an EPS of $1.62 in its last earnings report, beating expectations of $1.545. Following the earnings report the stock price went down -1.678%.
Which hedge fund is a major shareholder of Addus HomeCare Corporation?
Currently, no hedge funds are holding shares in ADUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Addus Homecare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$129.38 (37.17% Upside)
$129.38 (37.17% Upside)
Blogger Sentiment
Bullish
ADUS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 10.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $46.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 8.3%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.17%
12-Months-Change
Fundamentals
Return on Equity
9.34%
Trailing 12-Months
Asset Growth
2.00%
Trailing 12-Months
Company Description
Addus HomeCare Corporation
Addus HomeCare Corporation, through its various subsidiaries, offers essential personal support services across the United States. The company primarily assists seniors, individuals with chronic illnesses or disabilities, and those at risk of hospitalization or institutionalization. Its operations are structured into three primary segments: Personal Care, Hospice, and Home Health. The Personal Care division delivers non-medical assistance with daily living activities, including help with personal hygiene (bathing, grooming, oral care), eating, dressing, medication reminders, meal preparation, household chores, and transportation. Through its Hospice segment, Addus provides compassionate palliative nursing care, social work, spiritual guidance, homemaker services, and bereavement support to terminally ill individuals and their families. The Home Health segment delivers professional skilled nursing care alongside physical, occupational, and speech therapy for patients recovering from illness or following a hospital discharge. Addus HomeCare's diverse client base includes federal, state, and local government entities, managed care organizations, commercial insurance providers, and private-paying individuals. As of December 31, 2021, the company served consumers through a network of 206 offices located across 22 states. Established in 1979, Addus HomeCare Corporation is headquartered in Frisco, Texas.
ADUS Company Deck
ADUS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a broadly positive operational and financial picture: solid top-line growth (+7.7% revenue), meaningful EPS and adjusted EBITDA improvements, strong operating cash flow ($52.4M) and a strengthened balance sheet with reduced bank debt and sizable revolver availability. Personal Care and Hospice were key growth drivers (Personal Care same-store +6.5%; Hospice ADC +8.2%). Management also highlighted progress on productivity (caregiver app), hiring, and targeted M&A (entry into Indiana). Challenges noted include a weather-driven $1.5M revenue hit, elevated DSOs (timing-driven), a YoY decline in home health revenue, and a reversion in hospice revenue-per-day dynamics. Overall, positives (multiple strong metrics, cash flow and M&A runway, operating improvements) outweigh the contained challenges and one-time items.View all ADUS earnings summariesADUS Stock 12 Month Forecast
Average Price Target
$129.38
▲(37.17% Upside)
Technical Analysis
National Healthcare
―
Select Medical
―
US Physical Therapy
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.87% Insiders
36.52% Mutual Funds
34.14% Other Institutional Investors
3.89% Public Companies and
Individual Investors